JPWO2022216856A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022216856A5
JPWO2022216856A5 JP2023561278A JP2023561278A JPWO2022216856A5 JP WO2022216856 A5 JPWO2022216856 A5 JP WO2022216856A5 JP 2023561278 A JP2023561278 A JP 2023561278A JP 2023561278 A JP2023561278 A JP 2023561278A JP WO2022216856 A5 JPWO2022216856 A5 JP WO2022216856A5
Authority
JP
Japan
Prior art keywords
peptide
cells
optionally
polypeptide
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516542A5 (https=
JP2024516542A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/023714 external-priority patent/WO2022216856A1/en
Publication of JP2024516542A publication Critical patent/JP2024516542A/ja
Publication of JP2024516542A5 publication Critical patent/JP2024516542A5/ja
Publication of JPWO2022216856A5 publication Critical patent/JPWO2022216856A5/ja
Pending legal-status Critical Current

Links

JP2023561278A 2021-04-06 2022-04-06 Ｍｈｃクラスｉペプチドを含む方法および組成物 Pending JP2024516542A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163171137P 2021-04-06 2021-04-06
US63/171,137 2021-04-06
PCT/US2022/023714 WO2022216856A1 (en) 2021-04-06 2022-04-06 Methods and compositions comprising mhc class i peptides

Publications (3)

Publication Number Publication Date
JP2024516542A JP2024516542A (ja) 2024-04-16
JP2024516542A5 JP2024516542A5 (https=) 2025-08-20
JPWO2022216856A5 true JPWO2022216856A5 (https=) 2025-08-20

Family

ID=83546562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561278A Pending JP2024516542A (ja) 2021-04-06 2022-04-06 Ｍｈｃクラスｉペプチドを含む方法および組成物

Country Status (4)

Country Link
US (1) US20240218019A1 (https=)
EP (1) EP4320145A4 (https=)
JP (1) JP2024516542A (https=)
WO (1) WO2022216856A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240133853A (ko) * 2023-02-28 2024-09-05 루다큐어 주식회사 신규 펩타이드 및 이의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1430112A4 (en) * 2001-09-24 2005-06-15 Nuvelo Inc NEW NUCLEIC ACIDS AND POLYPEPTIDES
US8361780B2 (en) * 2005-06-30 2013-01-29 University Of Georgia Research Foundation, Inc. Biological system and assay for identifying modulators of tubulin ligases
US8791233B2 (en) * 2011-05-24 2014-07-29 Northwestern University Maspin-based peptides and methods of use thereof
EP3075389A1 (en) * 2015-03-31 2016-10-05 Technische Universität München T cell receptors and peptides derived by mutations for the treatment of cancer
TW202523682A (zh) * 2015-05-20 2025-06-16 美商博德研究所有限公司 共有之gata3相關之腫瘤特異性新抗原
FI3436048T3 (fi) * 2016-03-31 2025-09-15 Biontech Us Inc Neoantigeeneja ja niiden käyttömenetelmiä
WO2018213803A1 (en) * 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
HUE061840T2 (hu) * 2017-07-12 2023-08-28 Nouscom Ag Egy univerzális vakcina, amely közös tumor neoantigéneken alapul a mikroszatellita-instabilitás (MSI) rákos megbetegedések megelõzésére és kezelésére
KR20210040355A (ko) * 2018-06-19 2021-04-13 바이오엔테크 유에스 인크. 네오항원 및 이의 용도

Similar Documents

Publication Publication Date Title
US20250188145A1 (en) Tcr and peptides
US20240374728A1 (en) T Cell Modification
EP3099708B1 (en) Methods and compositions for producing a cell expressing a t cell receptor
JP7760524B2 (ja) 改善されたｔ細胞製造プロセス
CN120399034B (zh) 靶向prame肽的t细胞受体及其制备方法
US20240000834A1 (en) Ras mutant epitope peptide and t cell receptor recognizing ras mutant
JP2019536429A (ja) ポリオーマウイルスのための免疫療法
JPWO2022216856A5 (https=)
JPWO2021163562A5 (https=)
JPWO2022225852A5 (https=)
JPWO2023004289A5 (https=)
WO2024243807A1 (zh) 靶向ny-eso-1的高亲和力t细胞受体及其应用
WO2026040998A1 (zh) Tp53突变体表位肽和特异性t细胞受体及其应用
HK40117446A (en) T cell modification
CN119325506A (zh) 维持调节性t细胞的抑制活性的方法
JP2025516264A (ja) 多重化ｔ細胞受容体組成物、その併用療法、及び使用
JPWO2021092223A5 (https=)